, Volume 78, Issue 19–20, pp 1245–1250 | Cite as

Validated Stability-Indicating Method for Alendronate Sodium Employing Zwitterionic Hydrophilic Interaction Chromatography Coupled with Charged Aerosol Detection

  • Surapuraju Pavan Kumar Raju
  • Mallikarjun Narayanam
  • Banothu Kranthi Kumar
  • Sreeram Tejaswee
  • Saranjit SinghEmail author


Alendronate sodium is widely used in the treatment of osteoporosis and Paget’s disease. The HPLC method development for alendronate sodium, in particular, is challenging owing to the absence of chromophoric group and its high polarity. In the present study, a short and simple isocratic method was developed involving hydrophilic interaction liquid chromatography, coupled with a charged aerosol detector. The developed method was validated according to the ICH Q2(R1) guideline and was successfully applied for the analysis of a marketed formulation containing the drug.


CAD HILIC Alendronate sodium 


  1. 1.
    Dejaegher B, Vander Heyden Y (2010) J Sep Sci 33:698–715CrossRefGoogle Scholar
  2. 2.
    Almeling S, Ilko D, Holzgrabe U (2012) J Pharm Biomed Anal 69:50–63CrossRefGoogle Scholar
  3. 3.
    Ligor M, Studzinska S, Horna A, Buszewski B (2013) Crit Rev Anal Chem 43:64–78CrossRefGoogle Scholar
  4. 4.
    Hutchinson JP, Li J, Farrell W, Groeber E, Szucs R, Dicinoski G, Haddad PR (2011) J Chromatogr A 1218:1646–1655CrossRefGoogle Scholar
  5. 5.
    Buszewski B, Noga S (2012) Anal Bioanal Chem 402:231–247CrossRefGoogle Scholar
  6. 6.
    Di Palma S, Boersema PJ, Heck AJR, Mohammed S (2011) Anal Chem 83:3440–3447CrossRefGoogle Scholar
  7. 7.
    Jia S, Park JH, Lee J, Kwon SW (2011) Talanta 85:2301–2306CrossRefGoogle Scholar
  8. 8.
    Nováková L, Solichová D, Solich P (2009) J Chromatogr A 1216:4574–4581CrossRefGoogle Scholar
  9. 9.
    Huang Z, Richards MA, Zha Y, Francis R, Lozano R, Ruan J (2009) J Pharm Biomed Anal 50:809–814CrossRefGoogle Scholar
  10. 10.
    Zacharis CK, Tzanavaras PD (2008) J Pharm Biomed Anal 48:483–496CrossRefGoogle Scholar
  11. 11.
    Al Deeb SK, Hamdan II, Al Najjar SM (2004) Talanta 64:695–702CrossRefGoogle Scholar
  12. 12.
    Ptacek P, Klima J, Macek J (2002) J Chromatogr B 767:111–116CrossRefGoogle Scholar
  13. 13.
    Tsai EW, Ip DP, Brooks MA (1992) J Chromatogr A 596:217–224CrossRefGoogle Scholar
  14. 14.
    Reddy PS, Babu SK, Kumar N, Balakrishna P (2012) J Chil Chem Soc 57:1232–1234CrossRefGoogle Scholar
  15. 15.
    Han YHR, Qin XZ (1996) J Chromatogr A 719:345–352CrossRefGoogle Scholar
  16. 16.
    Reed DG, Martin GP, Konieczny JM, Brooks MA (1995) J Pharm Biomed Anal 13:1055–1058CrossRefGoogle Scholar
  17. 17.
    Singh S, Bakshi M (2000) Pharm Technol 4:1–14Google Scholar
  18. 18.
    Guideline ICH (2005) Validation of analytical procedures: text and methodologyGoogle Scholar
  19. 19.
    Holzgrabe U, Nap CJ, Almeling S (2010) J Chromatogr A 1217:294–301CrossRefGoogle Scholar
  20. 20.
    Holzgrabe U, Nap CJ, Kunz N, Almeling S (2011) J Pharm Biomed Anal 56:271–279CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Surapuraju Pavan Kumar Raju
    • 1
  • Mallikarjun Narayanam
    • 1
  • Banothu Kranthi Kumar
    • 1
  • Sreeram Tejaswee
    • 1
  • Saranjit Singh
    • 1
    Email author
  1. 1.Department of Pharmaceutical AnalysisNational Institute of Pharmaceutical Education and Research (NIPER)MohaliIndia

Personalised recommendations